WE ARE HIRING!

Details are here.

The Gujarian Research Group

Dr. Shashi Gujar's lab focuses on understanding how cancers develop, and then using that knowledge to educate our own immune system to fight cancers.

Immunotherapies represent the most promising modern-age modalities for the treatment of cancers. These immunotherapies promote anti-cancer immunity which not only eliminates existing cancer cells, but also maintains an active surveillance against future cancer relapse.

Dr. Gujar discovered that oncolytic viruses, known for their cancer-killing properties, additionally re-educate the immune system to recognize, attack, and eliminate cancer cells. Indeed, such awakening of immune system is believed to be the key to achieve long-term cancer-free health.

Using the next generation OMICs platforms in the context of oncolytic viruses, Dr. Gujar aims to develop innovative and clinically desired immunotherapies for the prevention and treatment of cancers.

The current focus of this research program encompasses the multi-disciplinary collaborative research in the fields of oncolytic viruses, applied immunomics, cancer biology, and cell metabolism.

Know More about us